214 related articles for article (PubMed ID: 31785996)
1. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.
Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S
Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996
[TBL] [Abstract][Full Text] [Related]
2. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
3. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FEZF1-AS1 in human cancers.
Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer.
Moazzen H; Rajabi A; Safaralizadeh R
Pathol Res Pract; 2023 Aug; 248():154639. PubMed ID: 37364417
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
[TBL] [Abstract][Full Text] [Related]
9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
12. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis in gastric cancer: Evidence from published studies and followed up verification.
Duan F; Li Y; Feng Y; Niu G; Chai J; Wang K
Cancer Med; 2023 Feb; 12(4):4227-4235. PubMed ID: 36164273
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer.
Yu S; Yang D; Ye Y; Liu P; Chen Z; Lei T; Pu J; Liu L; Wang Z
Cancer Sci; 2019 Jul; 110(7):2211-2225. PubMed ID: 31069893
[TBL] [Abstract][Full Text] [Related]
14. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
Zhang HH; Li AH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
[No Abstract] [Full Text] [Related]
17. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G
Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170
[TBL] [Abstract][Full Text] [Related]
18. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis.
Zeng Z; Bo H; Gong Z; Lian Y; Li X; Li X; Zhang W; Deng H; Zhou M; Peng S; Li G; Xiong W
Tumour Biol; 2016 Jan; 37(1):729-37. PubMed ID: 26245991
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]